TheraSense Inc.
Division of Abbott Laboratories Inc.
www.therasense.com
Latest From TheraSense Inc.
Can Patents Be Wiped Out Because Of A Litigator's Misconduct? Regeneron Asks Supreme Court
Regeneron challenges Federal Circuit finding that withholding information in discovery constitutes inequitable conduct; district judge orders firm to pay Merus $10.5m in attorneys' fees and costs.
Regeneron's Patent Pratfall: First Inequitable Conduct, Now Possible Sanctions
After losing patent infringement suit against Merus involving antibody-producing mouse, Regeneron fights ruling that it withheld material information in prosecuting the patent.
The Wireless Age in Diabetes: Insulet Raises $50 Million
J&J Closes the Loop with Animas Acquisition
Company Information
- Industry
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
-
Medical Devices
- Monitoring Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders > Diabetes
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Abbott Laboratories Inc.
- Senior Management
-
W. Mark Lortz, CEO
Charles T Liamos, CFO & COO
Mark Tatro, VP, Fin.
Shawna Gvazdauskas, VP, Sales - Contact Info
-
TheraSense Inc.
Phone: (510) 749-5400
1360 South Loop Rd.
Alameda, CA 94502
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice